Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
CEO AND CHIEF MEDICAL OFFICER, Director
-
Stock Symbol
-
QNCX on Nasdaq
Dirk Thye - trading volume in the past year for Quince Therapeutics, Inc.
Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
Common Stock |
844K |
$591K |
$0.70 |
Aug 30, 2024 |
Direct |
|
|
Employee Stock Option (right to buy) |
1.5M |
|
|
Feb 1, 2024 |
Direct |
Common Stock |
|
Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.